chr5-71649202-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_022132.5(MCCC2):c.1322T>C(p.Ile441Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00137 in 1,614,198 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_022132.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCCC2 | NM_022132.5 | c.1322T>C | p.Ile441Thr | missense_variant | Exon 14 of 17 | ENST00000340941.11 | NP_071415.1 | |
MCCC2 | NM_001363147.1 | c.1208T>C | p.Ile403Thr | missense_variant | Exon 13 of 16 | NP_001350076.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00139 AC: 211AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000998 AC: 251AN: 251474Hom.: 1 AF XY: 0.00103 AC XY: 140AN XY: 135918
GnomAD4 exome AF: 0.00137 AC: 2000AN: 1461840Hom.: 5 Cov.: 32 AF XY: 0.00137 AC XY: 996AN XY: 727230
GnomAD4 genome AF: 0.00138 AC: 211AN: 152358Hom.: 0 Cov.: 32 AF XY: 0.00145 AC XY: 108AN XY: 74500
ClinVar
Submissions by phenotype
3-methylcrotonyl-CoA carboxylase 2 deficiency Uncertain:4
- -
- -
This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 441 of the MCCC2 protein (p.Ile441Thr). This variant is present in population databases (rs139852818, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with 3-methycrotonyl-CoA carboxylase deficiency and mitochondrial complex I deficiency (PMID: 20818383, 26764160, 27601257). ClinVar contains an entry for this variant (Variation ID: 203808). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MCCC2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not specified Uncertain:1
Variant summary: MCCC2 c.1322T>C (p.Ile441Thr) results in a non-conservative amino acid change located in the acetyl-coenzyme A carboxyltransferase, C-terminal domain (IPR011763) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.001 in 252008 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in MCCC2 causing Methylcrotonyl-CoA Carboxylase Deficiency (0.001 vs 0.0042), allowing no conclusion about variant significance. c.1322T>C has been reported in the literature in individuals affected with Methylcrotonyl-CoA Carboxylase Deficiency (e.g. Fonseca_2016, Martin-Rivada_2022) and in an individual with mitochondrial complex I deficiency (Calvo_2010). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 20818383, 26764160, 27601257, 35281663). ClinVar contains an entry for this variant (Variation ID: 203808). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Methylcrotonyl-CoA carboxylase deficiency Uncertain:1
- -
MCCC2-related disorder Uncertain:1
The MCCC2 c.1322T>C variant is predicted to result in the amino acid substitution p.Ile441Thr. This variant was reported in at least three individuals with newborn screening/biochemical test results suggestive of 3-methylcrotonyl-CoA carboxylase 2 deficiency (Fonseca et al. 2016. PubMed ID: 27601257; P44 in Table S2 in Navarrete et al. 2019. PubMed ID: 30626930; Martín-Rivada Á et al. 2022. PubMed ID: 35281663). However, this variant is reported in 0.15% of alleles in individuals of Latino descent in gnomAD, which is relatively high for a pathogenic variant. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25087612, 20818383, 26764160, 20818363, 35281663, 30626930, 27601257) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at